JPH0228105A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0228105A JPH0228105A JP15960088A JP15960088A JPH0228105A JP H0228105 A JPH0228105 A JP H0228105A JP 15960088 A JP15960088 A JP 15960088A JP 15960088 A JP15960088 A JP 15960088A JP H0228105 A JPH0228105 A JP H0228105A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- acids
- organic
- amino acids
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 42
- 150000001413 amino acids Chemical class 0.000 claims abstract description 42
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 42
- 229960004705 kojic acid Drugs 0.000 claims abstract description 42
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 42
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- 239000002253 acid Substances 0.000 claims abstract description 16
- 230000007935 neutral effect Effects 0.000 claims abstract description 14
- 230000002378 acidificating effect Effects 0.000 claims abstract description 13
- 150000001991 dicarboxylic acids Chemical class 0.000 claims abstract description 9
- 150000000000 tetracarboxylic acids Chemical class 0.000 claims abstract description 9
- 150000007513 acids Chemical class 0.000 claims abstract description 8
- 150000002763 monocarboxylic acids Chemical class 0.000 claims abstract description 7
- 150000003628 tricarboxylic acids Chemical class 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 abstract description 40
- -1 glycine or alanine) Chemical class 0.000 abstract description 30
- 150000001875 compounds Chemical class 0.000 abstract description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000004471 Glycine Substances 0.000 abstract description 3
- 235000013922 glutamic acid Nutrition 0.000 abstract description 3
- 239000004220 glutamic acid Substances 0.000 abstract description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 2
- 239000004472 Lysine Substances 0.000 abstract description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 2
- 235000004279 alanine Nutrition 0.000 abstract description 2
- 239000000783 alginic acid Substances 0.000 abstract description 2
- 235000010443 alginic acid Nutrition 0.000 abstract description 2
- 229920000615 alginic acid Polymers 0.000 abstract description 2
- 229960001126 alginic acid Drugs 0.000 abstract description 2
- 150000004781 alginic acids Chemical class 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000001384 succinic acid Substances 0.000 abstract 1
- 230000002087 whitening effect Effects 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- 229940024606 amino acid Drugs 0.000 description 35
- 239000012071 phase Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000008346 aqueous phase Substances 0.000 description 15
- 239000006210 lotion Substances 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 229940057995 liquid paraffin Drugs 0.000 description 8
- 235000013871 bee wax Nutrition 0.000 description 7
- 239000012166 beeswax Substances 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 7
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000008294 cold cream Substances 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 229960002429 proline Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- 229930182821 L-proline Natural products 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 206010040829 Skin discolouration Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229950006451 sorbitan laurate Drugs 0.000 description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFULXQXOVCEBGZ-LVDJIYQJSA-N 2,3-dihydroxypropyl (2S)-5-oxopyrrolidine-2-carboxylate 16-methylheptadecanoic acid Chemical compound OCC(O)COC(=O)[C@@H]1CCC(=O)N1.CC(C)CCCCCCCCCCCCCCC(O)=O FFULXQXOVCEBGZ-LVDJIYQJSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QEVGZEDELICMKH-UHFFFAOYSA-N Diglycolic acid Chemical compound OC(=O)COCC(O)=O QEVGZEDELICMKH-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000589236 Gluconobacter Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000302544 Luffa aegyptiaca Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Abstract
Description
【発明の詳細な説明】
産業上の利用分−−−−
本発明はコウジ酸を含む安定な化粧料に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION Industrial Applications The present invention relates to stable cosmetics containing kojic acid.
従来の技術
化粧料の中には、日焼けによりメラニンが沈着した皮膚
を色白にする、いわゆる色白化粧料がある。色白化粧料
の有効成分としてはビタミンCおよびその誘導体などが
用いられるが、近年になり色白効果が高くしかも安全な
化合物として=1ウジ酸が注目されている。BACKGROUND OF THE INVENTION Among conventional cosmetics, there are so-called fair-skinned cosmetics that whiten skin where melanin has been deposited due to sunburn. Vitamin C and its derivatives are used as active ingredients in skin-lightening cosmetics, but in recent years, =1-udic acid has attracted attention as a safe compound that has a high skin-lightening effect.
しかし、コウジ酸を配合した化粧料は安定性に難点があ
る。すなわち、コウジ酸を配合した化粧料は経時的に色
ま/48虚p Hが変化し、製品として満足のいくもの
が得られない。However, cosmetics containing kojic acid have a drawback in stability. In other words, the color/48 false pH of cosmetics containing kojic acid changes over time, making it impossible to obtain a satisfactory product.
従来、コウジ酸を安定に含む化粧料に関する技術は報告
されていない。Conventionally, no technology regarding cosmetics stably containing kojic acid has been reported.
本発明が解決しようとする課題は、コウジ酸を含む化粧
料を安定化することにある。The problem to be solved by the present invention is to stabilize cosmetics containing kojic acid.
鳳■を解決するための手段および作用 上記課題は、本発明により解決される。Means and actions to solve the problem The above problems are solved by the present invention.
すなわち、本発明は以下のような3種類のコウジ酸含有
化粧料に関するものであり、いずれも上記課題を解決す
るものである。That is, the present invention relates to the following three types of kojic acid-containing cosmetics, all of which solve the above problems.
まず第1の発明は色相が安定な化粧料に間するものであ
り、有機モノカルボン酸、中性アミノ酸、塩基性アミノ
酸およびこれらの塩から選ばれる少なくとも1種とコウ
ジ酸を含有することを特徴とする化粧料である。The first invention is for a cosmetic with stable hue, and is characterized by containing at least one selected from organic monocarboxylic acids, neutral amino acids, basic amino acids, and salts thereof and kojic acid. It is a cosmetic product that
第2の発明はpHが安定な化粧料に関するものであり、
有機ジカルボン酸、有機テトラカルボン酸、高分子ポリ
カルボン酸、酸性アミノ酸およびこれらの塩から選ばれ
る少なくとも1種とコウジ酸を含有することを特徴とす
る化粧料である。The second invention relates to pH-stable cosmetics,
This cosmetic is characterized by containing kojic acid and at least one selected from organic dicarboxylic acids, organic tetracarboxylic acids, high-molecular polycarboxylic acids, acidic amino acids, and salts thereof.
第3の発明は色相とpHが共に安定な化粧料に関するも
のであり、(A)有機モノカルボン酸、中性アミノ酸、
塩基性アミノ酸およびこれらの塩から選ばれる少なくと
も1種、(B)有機ジカルボン酸、有機トリカルボン酸
、有機テトラカルボン酸、高分子ポリカルボン酸、酸性
アミノ酸およびこれらの塩から選ばれる少なくとも1種
、および(C)コウジ酸の3成分を必須成分とすること
を特徴とする化粧料である。The third invention relates to a cosmetic that is stable in both hue and pH, and includes (A) an organic monocarboxylic acid, a neutral amino acid,
(B) at least one selected from basic amino acids and salts thereof; (B) at least one selected from organic dicarboxylic acids, organic tricarboxylic acids, organic tetracarboxylic acids, high molecular weight polycarboxylic acids, acidic amino acids and salts thereof; and (C) A cosmetic product characterized by containing three components of kojic acid as essential components.
本発明のコウジ酸は、正式には5−ヒドロキシ−2−(
ヒドロキシメチル)−4−ピロンと呼ばれ、アスペルギ
ルス属、グルコノバクタ−属などの菌の醗酵代謝物から
得られる化合物である。The kojic acid of the present invention is formally known as 5-hydroxy-2-(
It is called hydroxymethyl)-4-pyrone and is a compound obtained from fermentation metabolites of bacteria such as Aspergillus and Gluconobacter.
本発明の第1の発明に用いる有機モノカルボン酸、中性
アミノ酸、塩基性アミノ酸は以下のような化合物である
。すなわち、有機モノカルボン酸としては乳酸、グリコ
ール酸、酢酸、プロピオン酸、ウロカニン酸、安息香酸
、ピロリドンカルボン酸、グリチルレチン酸、ニコチン
酸、オロチン酸、ビタミンA酸、αまたはγ−リルン酸
などであり、中性アミノ酸としてはアラニン、β−アラ
ニン、γ−アミノ酪酸、ε−アミノカプロン酸、システ
ィン、グリシン、ヒスチジン、オキシプロリン、インロ
イシン、ロイシン、メチオニン、フェニルアラニン、プ
ロリン、スレオニン、トリプトファンなどであり、塩基
性アミノ酸としてはアルギニン、リジン、オルニチンな
どである。本発明においてはこれらの塩もコウジ酸の安
定に有効である。このような塩としては、有機モノカル
ボン酸の場合はそれらのアルカリ金属塩、アルカノール
アミン塩および塩基性アミノ酸塩であり、中性アミノ酸
の場合はそれらのアルカリ金属塩、アルカノールアミン
塩であり、塩基性アミノ酸塩の場合は塩酸塩などである
。なお、本発明に用いられる中性アミノ酸、塩基性アミ
ノ酸は光学活性体、ラセミ体のいずれでもよい。The organic monocarboxylic acid, neutral amino acid, and basic amino acid used in the first aspect of the present invention are the following compounds. That is, organic monocarboxylic acids include lactic acid, glycolic acid, acetic acid, propionic acid, urocanic acid, benzoic acid, pyrrolidonecarboxylic acid, glycyrrhetinic acid, nicotinic acid, orotic acid, vitamin A acid, α- or γ-lylunic acid, and the like. , neutral amino acids include alanine, β-alanine, γ-aminobutyric acid, ε-aminocaproic acid, cysteine, glycine, histidine, oxyproline, inleucine, leucine, methionine, phenylalanine, proline, threonine, tryptophan, etc. Examples of the amino acids include arginine, lysine, and ornithine. In the present invention, these salts are also effective in stabilizing kojic acid. Such salts include, in the case of organic monocarboxylic acids, their alkali metal salts, alkanolamine salts and basic amino acid salts, and in the case of neutral amino acids, their alkali metal salts, alkanolamine salts, and base Examples of amino acid salts include hydrochloride. Note that the neutral amino acid and basic amino acid used in the present invention may be either an optically active form or a racemic form.
本発明の第2の発明に用いる有機ジカルボン酸、有機テ
トラカルボン酸、高分子ポリカルボン酸、酸性アミノ酸
は以下のような化合物である。The organic dicarboxylic acid, organic tetracarboxylic acid, high molecular weight polycarboxylic acid, and acidic amino acid used in the second invention of the present invention are the following compounds.
すなわち、有機ジカルボン酸としてはコハク酸、シュウ
酸、酒石酸、リンゴ酸、ジグリコール酸などであり、有
機テトラカルボン酸としてはエチレンジアミン4酢酸な
どであり、高分子ポリカルボン酸としてはアルギン酸、
ヒアルロン酸、コンドロイチン硫酸などであり、酸性ア
ミノ酸としてはグルタミン酸、アスパラギン酸などであ
る9本発明においてはこれらの塩もコウジ酸の安定に有
効である。塩としては、有機ジカルボン酸、有機テトラ
カルボン酸および高分子ポリカルボン酸の場合はそれら
のアルカリ金属塩、アルカノールアミン塩、塩基性アミ
ノ酸塩であり、酸性アミノ酸の場合はそれらのアルカリ
金属塩、アルカノールアミン塩、塩基性アミノ酸塩であ
る。That is, organic dicarboxylic acids include succinic acid, oxalic acid, tartaric acid, malic acid, diglycolic acid, etc., organic tetracarboxylic acids include ethylenediaminetetraacetic acid, and polymeric polycarboxylic acids include alginic acid,
Hyaluronic acid, chondroitin sulfate, etc., and acidic amino acids include glutamic acid, aspartic acid, etc. 9 In the present invention, these salts are also effective in stabilizing kojic acid. Salts include organic dicarboxylic acids, organic tetracarboxylic acids, and polymeric polycarboxylic acids, such as their alkali metal salts, alkanolamine salts, and basic amino acid salts, and acidic amino acids, such as their alkali metal salts and alkanol salts. Amine salts and basic amino acid salts.
第3の発明の成分(A)の有機モノカルボン酸、中性ア
ミノ酸、塩基性アミノ酸と成分(B)の有機ジカルボン
酸、有機テトラカルボン酸、高分子ポリカルボン酸、酸
性アミノ酸はそれぞれ第1、第2の発明に使用したもの
を用いることができるが、第3の発明の成分(B)中の
有機トリカルボン酸としてはクエン酸が挙げられる。The organic monocarboxylic acid, neutral amino acid, basic amino acid of the component (A) of the third invention and the organic dicarboxylic acid, organic tetracarboxylic acid, polymeric polycarboxylic acid, and acidic amino acid of the component (B) are the first, Although the organic tricarboxylic acid used in the second invention can be used, the organic tricarboxylic acid in the component (B) of the third invention includes citric acid.
本発明の化粧料におけるコウジ酸の配合量は特に限定さ
れないが、通常は0.01〜5重量%、好ましくは0.
1〜3重量%である。The amount of kojic acid blended in the cosmetic of the present invention is not particularly limited, but is usually 0.01 to 5% by weight, preferably 0.01 to 5% by weight.
It is 1 to 3% by weight.
第1の発明における有機モ、ノカルボン酸、中性アミノ
酸、塩基性アミノ酸およびこれらの塩から選はれる少な
くとも1種の化合物の配合量は、0.05−7重量%、
好ましくは0.1〜5重醍%である。0.05重敗%未
満では安定性に対する効果か乏1−<、また7重量%を
超えて配合しても安定性は変化!−ない。In the first invention, the blending amount of at least one compound selected from organic monocarboxylic acids, neutral amino acids, basic amino acids, and salts thereof is 0.05-7% by weight,
Preferably it is 0.1 to 5%. If it is less than 0.05% by weight, the effect on stability will be poor (1-<), and even if it is added more than 7% by weight, the stability will change! -No.
第2の発明における有機ジカルボン酸、有機デ1ヘラカ
ルだ1<ン酸、高分子ポリカルボン酸、酸性アミノ酸お
よびこれらの塩から選ばれる少なくとも1種の配り割合
は、0,05〜7重ψ%、好ましくは0.1〜5重盪%
である。0.05重量%未満では安定性に対する効果が
乏しく、また7重量?舌を超えて配合しても安定性は変
化しない。In the second invention, the distribution ratio of at least one selected from organic dicarboxylic acids, organic dicarboxylic acids, polymeric polycarboxylic acids, acidic amino acids, and salts thereof is 0.05 to 7% by weight. , preferably 0.1 to 5% by weight
It is. If it is less than 0.05% by weight, the effect on stability is poor, and 7% by weight? Even if it is blended beyond the tongue, the stability does not change.
第3の発明における成u(A)と成分(B)のRh割合
は、(A)成分と(F3)成分の重琥比が1 / 9〜
Q 、、/ l−好ましくは2/8〜8/2の範囲て゛
、両成分の合計の配合量が化粧料当たり0.05へ一7
重量%、好ましくは0.1〜5重量%で、りる。In the third invention, the Rh ratio of the component u (A) and the component (B) is such that the rheology ratio of the component (A) and the component (F3) is 1/9 to 1/9.
Q,,/l - Preferably in the range of 2/8 to 8/2, the total blending amount of both components is 0.05 to 7 per cosmetic.
% by weight, preferably from 0.1 to 5% by weight.
本発明の化粧料はクリーム、乳液、ローション、バック
、化粧水等使用目的に応じてその剤形を適宜選択できる
。The dosage form of the cosmetic composition of the present invention can be appropriately selected depending on the purpose of use, such as cream, milky lotion, lotion, bag, lotion, etc.
本発明の化粧料の製造方法は特に限定されないず、通常
の化粧料の製法に準じて行えばよい。例えば、乳化型の
化粧料の場合は、コウジ酸と本発明の各種有機酸、アミ
ノ酸等を水相に溶解し、化粧品原料として一般に使用さ
れている乳化剤および油相成分と充分に攪拌し、当業者
間で行われている通常の方法で乳化すればよく、乳化の
状態はW / O1○/Wのいずれでもよい。The method for producing the cosmetic of the present invention is not particularly limited, and may be carried out in accordance with a conventional method for producing cosmetics. For example, in the case of emulsified cosmetics, kojic acid and various organic acids, amino acids, etc. of the present invention are dissolved in an aqueous phase, and thoroughly stirred with an emulsifier and oil phase components commonly used as cosmetic raw materials. Emulsification may be carried out by a common method used among manufacturers, and the emulsification state may be W/O1○/W.
なお、本発明における有機酸、アミノ酸等は、それらを
別々に配合してもよいし、あるいはこれらの成分を主成
分として予め配合されて市販されているものく例えば、
味の素■製「プロデュウ100J、[ブロデュウ 20
0J )を使用してもよい。In addition, the organic acids, amino acids, etc. in the present invention may be blended separately, or may be commercially available pre-blended with these components as the main ingredients.
Ajinomoto ■ “Prodew 100J, [Brodew 20]”
0J) may be used.
本発明の化粧料には、安定性を損なわない範囲で、必要
に応じて抗炎症剤、ビタミン類、収斂剤、ホルモン類、
保湿剤、清涼化剤、メラニン形成抑制剤、その他動植物
エキスなど化粧料に慣用されている補助剤やエラスチン
、キチン、キトサン、生理活性物質など特殊な成分を添
加してもよい
以下゛、実施例により本発明をより詳細に説明する9
笈−mxi−
第1表に示す濃度になるように各試験試料を計り、コウ
ジ酸の2%水溶液2’5gを加えた。3%水酸化すI−
リウム水溶液または塩酸によりpHを5.5に調悠した
。さらに蒸留水25gを加えた。The cosmetics of the present invention may optionally contain anti-inflammatory agents, vitamins, astringents, hormones, etc., as long as they do not impair stability.
Auxiliary agents commonly used in cosmetics such as moisturizing agents, cooling agents, melanin formation inhibitors, and other animal and plant extracts, as well as special ingredients such as elastin, chitin, chitosan, and physiologically active substances, may be added. The present invention will be described in more detail below.9 笈-mxi- Each test sample was weighed to give the concentration shown in Table 1, and 2'5 g of a 2% aqueous solution of kojic acid was added. 3% hydroxide I-
The pH was adjusted to 5.5 using an aqueous solution of sodium chloride or hydrochloric acid. Furthermore, 25 g of distilled water was added.
このものを110°Cの恒温槽に1〜2週間静置した後
、7120口mにおける吸光度を測定し色相の変化を調
べた。なお色相の変化は、開始時の吸光度をaとし、4
0°C1週間後、2週間後の吸光度をbとし、てb l
aの比率により評価した。その結果を第1表に示す。After leaving this product in a constant temperature bath at 110° C. for 1 to 2 weeks, the absorbance at 7120 mm was measured to examine changes in hue. For the change in hue, the absorbance at the beginning is a, and 4
The absorbance after 1 week and 2 weeks at 0°C is b, and b l
It was evaluated based on the ratio of a. The results are shown in Table 1.
表中の数値が小さいほど着色が少ないことを意味する。The smaller the number in the table, the less coloring.
第1表
朶−施−例2 コールドクリーム
(油相) wt%・
流動パラフィン 40.0・固形
パラフィン 10.0・ミツロウ
13.0・ポリオキシエ
チレン(2)セチル
エーテル 24・ポリ
オキシエチレン(5)オレイル
エーテル 4.0・ポリ
オキシエチレン(20)ソルビタンラウレート
0.7・パラオキシ安息香酸ブ
チル 012(水相)
・ホウ砂 1,3・乳
酸 0.5・コウジ
酸 1.0・水
残油相を80℃に加熱し溶融
させ、別に水相を80℃に加熱し、油相を水相に攪拌混
合しながら加え、攪拌下30℃まで冷却してコールドク
リームを調製した。Table 1 - Example 2 Cold cream (oil phase) wt%
Liquid paraffin 40.0, solid paraffin 10.0, beeswax 13.0, polyoxyethylene (2) cetyl ether 24, polyoxyethylene (5) oleyl ether 4.0, polyoxyethylene (20) sorbitan laurate
0.7・Butyl paraoxybenzoate 012 (water phase) ・Borax 1,3・Lactic acid 0.5・Kojic acid 1.0・Water
The residual oil phase was heated to 80° C. to melt it, the aqueous phase was separately heated to 80° C., the oil phase was added to the aqueous phase with stirring, and the mixture was cooled to 30° C. while stirring to prepare a cold cream.
実施例3 コールドクリーム
(油相) wt%・
流動パラフィン 38.0・固形
パラフィン 120ミツロウ
12.0・ポリオキシエチレ
ン(2)セチル
エーテル 25・ポリ
オキシエチレン(5)オレイル
エーテル 4.トポリ
オキシエチレン(20)ソルビタンラウレート0.8
・パラオキシ安息香酸ブチル 0.2く水
相)
ニコチン酸 0・3・γ−
リルン酸 0.2・ビタミンA
酸 0.2・コウジ酸
1,0・水
残上記配合に基づき、実施例2に準じ
てコールドクリームを調製した。Example 3 Cold cream (oil phase) wt%
Liquid paraffin 38.0, solid paraffin 120 beeswax
12.0. Polyoxyethylene (2) Cetyl ether 25. Polyoxyethylene (5) Oleyl ether 4. Topolyoxyethylene (20) sorbitan laurate 0.8 ・Butyl paraoxybenzoate 0.2 μm (aqueous phase) Nicotinic acid 0.3・γ-
Rilunic acid 0.2・vitamin A
Acid 0.2 Kojic acid
1,0・Wednesday
A cold cream was prepared according to Example 2 based on the above formulation.
4 バニシングクリーム
(油相)
・MC−ステアリン1′
・流動パラフィン
・イソブロビルミリスチレート
・チルコール2)
・水添ラノリン
・グリセリンモノステアレート
・ポリオキシエチレン(20)セチル
エーテル
パラオキシ安息香酸プロピル
(水相)
・コウジ酸
・PCAソーダ(50%)31
・ε−アミノカプロン酸
・L−プロリン
・L−リジン塩酸塩
1.3−ブチレンクリコール
・パラオキシ安息香酸メチル
wt %
10.0
1.0
1.0
1.5
0.2
1.5
3.0
0.5
0.5
0.3
4.0
0.1
・水 残注)1ニステア
リン酸 用研ファインケミカル■製
注)2:オクタン酸セチル 用研ファインケミカル■製
注)3:DL−2−ピロリドン−5−カルボン酸ナトリ
ウム 味の素■製
上記配合に基づき、実施例2に準じてバニシングクリー
ムを調製した。4 Vanishing cream (oil phase) ・MC-stearin 1' ・Liquid paraffin ・Isobrobyl myristylate ・Tyrchol 2) ・Hydrogenated lanolin ・Glycerin monostearate ・Polyoxyethylene (20) Cetyl ether propyl paraoxybenzoate (water Phase) ・Kojic acid・PCA soda (50%) 31 ・ε-Aminocaproic acid・L-proline・L-lysine hydrochloride 1.3-Butylene glycol・Methyl paraoxybenzoate wt % 10.0 1.0 1. 0 1.5 0.2 1.5 3.0 0.5 0.5 0.3 4.0 0.1 ・Water Remaining note) 1 Nistearic acid Made by Yoken Fine Chemicals Note) 2: For cetyl octoate 3: Sodium DL-2-pyrrolidone-5-carboxylate Manufactured by Ajinomoto ■ Based on the above formulation, a vanishing cream was prepared according to Example 2.
実施例5 乳液
(油相) wt%・
スクワラン 5.0・ワセ
リン 20・ミツロウ
0.5・ソルビタンセ
スキオレイン酸エステル 0.8・ポリオキシエチレ
ン(5)オレイル
エーテル 1・2・パ
ラオキシ安息香酸プロピル 0. トパラオ
キシ安息香酸ブチル Q、 1(水相)
・プロピレングリコール 5.0・エ
タノール 5.0・カル
ボキシビニルポリマー(1%) 20.0・コウジ
酸 0,75・プロデュ
ウー10041 10.0・L−アルギ
ニン 0.]・香料
0. トパラオキシ安息香酸
メチル 0.1・水酸化ナトリウム
pH5,5とする量・水
残注)4:L−プロリン、PCAソーダ、乳酸ナ
トリウム、蛋白加水分解物の混合物(50%濃度)、味
の素■製
上記の配合に基づき、実施例2に準じて乳液を調製した
。Example 5 Emulsion (oil phase) wt%
Squalane 5.0, petrolatum 20, beeswax 0.5, sorbitan sesquioleate 0.8, polyoxyethylene (5) oleyl ether 1, 2, propyl paraoxybenzoate 0. Butyl toparaoxybenzoate Q, 1 (aqueous phase) ・Propylene glycol 5.0 ・Ethanol 5.0 ・Carboxyvinyl polymer (1%) 20.0 ・Kojic acid 0.75 ・Prodew 10041 10.0 ・L-Arginine 0 .. ]・Fragrance
0. Methyl toparaoxybenzoate 0.1 Sodium hydroxide
Amount/water to adjust pH to 5.5
Remaining note) 4: L-proline, PCA soda, sodium lactate, protein hydrolyzate mixture (50% concentration), manufactured by Ajinomoto ■ Based on the above formulation, a milky lotion was prepared according to Example 2.
実施例6 乳液
(油相) wt%・
流動パラフィン 10.0ミツロ
ウ 1.0・ステアリル
アルコール 1.4・63−ステアリ
ン51 1.2・ポリオキシエチレ
ン(10)グリセリルトリステアレート2.4
・ポリオキシエチレン(15)セチル
エーテル 0.8・パ
ラオキシ安息香酸ブチル 0,1(水相〉
・PCAソーダ 4.0・
L−スレオニン 1.0・コウ
ジ酸 2.0アラントイ
ン 0.2・パラオキシ安
息香酸メチル 0.1・混合植物抽出エキ
ス 0.5・水
残注)5ニステアリン酸、用研ファインケ
ミカル■製
上記配合に基づいて、実施例2に準じて乳液を調製した
。Example 6 Emulsion (oil phase) wt%
Liquid paraffin 10.0 Beeswax 1.0 stearyl alcohol 1.4 63-stearin 51 1.2 polyoxyethylene (10) glyceryl tristearate 2.4 polyoxyethylene (15) cetyl ether 0.8 Butyl paraoxybenzoate 0.1 (aqueous phase) PCA soda 4.0
L-Threonine 1.0・Kojic acid 2.0 Allantoin 0.2・Methyl paraoxybenzoate 0.1・Mixed plant extract 0.5・Water
Remaining note) 5 Nistearic acid, manufactured by Yoken Fine Chemicals ■ Based on the above formulation, a milky lotion was prepared according to Example 2.
実Ufiig 7 −一−イヒーI−
wt%
コウジ酸 0.5・D
L−メチオニン 0.2・D L
−2−ピロリドン−5−カルボン酸トリエタノールア
ミン 0.5・アロエエキス
0. トクチナシエキス
0.トヘチマエキス
0.1・炭酸カルシウム
0.2・エタノール
5.0・グリセリン
10,0・パラオキシ安息香酸メチル 0
.1・香料 0.1
・水酸化ナトリウム 0.1・
水 残上記全成分を加温
溶解した後、攪拌冷却して化粧水を調製した。Ufiig 7 -1-Ihi I- wt% Kojic acid 0.5・D
L-methionine 0.2・D L
-2-pyrrolidone-5-carboxylic acid triethanolamine 0.5・Aloe extract
0. Horse chestnut extract
0. Tohetima extract
0.1・Calcium carbonate
0.2・Ethanol
5.0・Glycerin
10,0-Methyl paraoxybenzoate 0
.. 1.Fragrance 0.1
・Sodium hydroxide 0.1・
Water After heating and dissolving all the remaining components above, the solution was stirred and cooled to prepare a lotion.
例8 パック− (A) ・コウジ酸 ・安息香酸ナトリウム ・L−オキシプロリン ・L−ロイシン ・ビーガム ・スクワラン ・プロピレングリコール ・ビタミンA ・ビタミンC ・シコンエキス ・パラオキシ安息香酸メチル ・水 (B) ・酸化亜鉛 ・カオリン (C) ・エタノール 上記A成分を溶解し膨潤させた後、 wt% 1.8 1.0 0、5 0.8 5.0 5.0 0.01 0.01 0.1 0.1 10.0 10.0 5、O B成分を加 え、次いでC成分を加え混練しパックを調製した。Example 8 Pack- (A) ・Kojic acid ・Sodium benzoate ・L-oxyproline ・L-leucine ・Begum ・Squalane ·Propylene glycol ・Vitamin A ・Vitamin C ・Shikon extract ・Methyl paraoxybenzoate ·water (B) ・Zinc oxide ・Kaolin (C) ·ethanol After dissolving and swelling the above component A, wt% 1.8 1.0 0, 5 0.8 5.0 5.0 0.01 0.01 0.1 0.1 10.0 10.0 5, O Add component B Then, component C was added and kneaded to prepare a pack.
以上の実施例2〜8の各化粧料を45℃、2ケ月間放置
したところ着色はわずかであり、充分商品として耐えう
るちのであった。When each of the cosmetics of Examples 2 to 8 was left at 45° C. for 2 months, there was only slight discoloration and the cosmetics could be used as commercial products.
比較例1.2
実施例2および5の配合から有機酸(塩)、中性アミノ
酸(塩)、塩基性アミノ酸(塩)を除いた化粧料を調製
しくpHは水酸化ナトリウムまたは塩酸で調整し実施例
2.5のものと合わせた)それぞれ比較例1.2とした
。これらを45℃における2ケ月間の着色試験に供した
。Comparative Example 1.2 A cosmetic was prepared by removing organic acids (salts), neutral amino acids (salts), and basic amino acids (salts) from the formulations of Examples 2 and 5. The pH was adjusted with sodium hydroxide or hydrochloric acid. Comparative Example 1.2 (combined with Example 2.5) was used as Comparative Example 1.2. These were subjected to a coloring test at 45° C. for 2 months.
試験前の試料を色差計(日本重色■製「色差計2−10
01DPJ )によりL(明るさ)、a(赤み)、b(
黄色)を測定し、試験後の色相を同様に測定して、それ
ぞれL′、 ′、b′として下記式よりΔEを算出した
。The sample before the test was measured using a color difference meter (“Color Meter 2-10” manufactured by Nippon Heavy Industries Ltd.).
01DPJ), L (brightness), a (redness), b (
Yellow) was measured, and the hue after the test was similarly measured, and ΔE was calculated from the following formula using L', ', and b', respectively.
ΔEが大きいほど着色の度合いが大きいことを意味する
。その結果を第2表に示す。The larger ΔE means the greater the degree of coloring. The results are shown in Table 2.
第2表
ΔE= + a−a ) +
(b−b’)2害UL倒ゴし
第3表に示す濃度になるように各試験試料を計り、コウ
ジ酸の2%水溶液25gを加えた。3%水酸化ナトリウ
ム水溶液または塩酸によりpHを5.5に調整した。さ
らに蒸留水25gを加えた。Table 2 ΔE= + a-a ) +
(b-b') 2 Harm UL was weighed to give each test sample a concentration shown in Table 3, and 25 g of a 2% aqueous solution of kojic acid was added. The pH was adjusted to 5.5 with a 3% aqueous sodium hydroxide solution or hydrochloric acid. Furthermore, 25 g of distilled water was added.
このものを40°Cの恒温槽に1〜2週間週間上置後、
pHを測定した。その結果を第3表に示す。After placing this in a constant temperature bath at 40°C for 1 to 2 weeks,
The pH was measured. The results are shown in Table 3.
(以下余白)
実一方り廻−1−Q クリーム
(油相) wt%・
ミツロウ 6.0・セタ
ノール 6.0・還元ラノ
リン 8.0スクワラン
30,0・親油型モノステアリ
ン酸グリセリン 3.0・ポリオキシエチレンソル
ビタン
モノラウレート 2.0パラ
オキシ安7C1香酸ブチル 0.2(水相
)
・プロピレングリコール 5.0・コ
ウジ酸 1.0・酒石酸
1.0・水酸化ナト
リウム p H5,6にする量・水
残油相を80℃に加熱し、水相を
別に80℃に加熱しておき、油相を水相に攪拌しながら
徐々に加える。攪拌しながら30℃まで冷却してクリー
ムを調製した。(Margins below) Seiichiori Mawari-1-Q Cream (oil phase) wt%・
Beeswax 6.0, Setanol 6.0, Reduced Lanolin 8.0 Squalane
30,0・Lipophilic glycerin monostearate 3.0・Polyoxyethylene sorbitan monolaurate 2.0 Paraoxyamne 7C1 butyl froate 0.2 (aqueous phase)・Propylene glycol 5.0・Kojic acid 1.0・Tartaric acid 1.0 ・Sodium hydroxide amount to make pH 5,6 ・Water
The residual oil phase is heated to 80° C., the aqueous phase is separately heated to 80° C., and the oil phase is gradually added to the aqueous phase with stirring. A cream was prepared by cooling to 30° C. while stirring.
実」1例11 り辺ニーK
(油相) wt%・ミ
ツロウ 7.0・セタノ
ール 5.0・還元ラノ
リン 7.5・スクワラン
28.0・親油型モノステアリ
ン酸グリセリン 3゜0・ポリオキシエチレンソル
ビタン
モノラウレート 2.0・パ
ラオキシ安店、香酸ブチル 0.2(水相
)
・プロピレングリコール 5.0・コ
ウジ酸 1.0・ヒアル
ロン酸 0.トコンドロイ
チン硫酸 1.0・水酸化ナトリウ
ム pH5,6にする量・水
残
実施例10に準じて、クリームを調製した。Fruit” 1 Example 11 Ribe K (oil phase) wt%・Beeswax 7.0・Cetanol 5.0・Reduced lanolin 7.5・Squalane
28.0・Lipophilic glyceryl monostearate 3゜0・Polyoxyethylene sorbitan monolaurate 2.0・Paraoxyamdeme, butyl fragrant 0.2 (aqueous phase)・Propylene glycol 5.0・Kojic acid 1 .0・Hyaluronic acid 0. Tochondroitin sulfate 1.0・Sodium hydroxide Amount to adjust pH to 5.6・Water
A cream was prepared according to the remaining Example 10.
害−施−例−し−12クリーム
(油相)
流動パラフィン
・固形パラフィン
・ワセリン
・ポリオキシエチレン(2)ジー2−
オクチルドデシル−N−ラウロイル
し一グルタミン酸エステル
N−ラウロイル−し−グルタミン酸
ポリオキシエチレン(5)ジステア
リルジエステル
イソプロピルミリステート
・セタノール
・ポリオキシエチレン(3)ステアリルエーテル
ポリオキシエチレン(8)ステアリル
エーテル
ポリオキシエチレン(20)セチル
エーテル
(水相)
wt%
3.2
1.5
1.0
2.0
0.5
0.2
・N−ラウロイル=L−グルタミン酸
モノナトリウム 0.2・ポリ
エチレングリコール400 0.2・プロピレ
ングリコール 2・コウジ酸
0.5・エチレンジアミン四
酢酸ジナトリウム 1.5・L−アスパラギン酸モノ
ナトリウム 0.5・水酸化ナトリウム
pH6,0にする量・パラオキシ安息香酸メチル
0.5・水 残
実施例10に準じてクリームを調製した。Harm - Example - Shi-12 Cream (oil phase) Liquid paraffin, solid paraffin, vaseline, polyoxyethylene (2) Di-2-octyldodecyl-N-lauroyl monoglutamic acid ester N-lauroyl-glutamic acid polyoxy Ethylene (5) Distearyl diester Isopropyl myristate/cetanol/polyoxyethylene (3) Stearyl ether polyoxyethylene (8) Stearyl ether polyoxyethylene (20) Cetyl ether (aqueous phase) wt% 3.2 1.5 1 .0 2.0 0.5 0.2 ・N-lauroyl=monosodium L-glutamate 0.2・Polyethylene glycol 400 0.2・Propylene glycol 2・Kojic acid
0.5. Disodium ethylenediaminetetraacetate 1.5. Monosodium L-aspartate 0.5. Sodium hydroxide
Amount to adjust pH to 6.0/Methyl paraoxybenzoate
0.5 Water A cream was prepared according to the remainder of Example 10.
実施例13 ミルクローション
(油相) wt%・
流動パラフィン 32・固形パ
ラフィン 4・セタノール
4・ソルビタンモノステ
アレート 1.5・ポリオキシエチレン(2
0)ソルビ
タンモノオレエート 2.8パラ
オキシ安息香酸プロピル 0.2(水相)
・コウジ酸 2゜・リン
ゴ酸 0.5・■−−
グルタミン酸 1.0ヒアルロ
ン酸 0.01・水酸化ナト
リウム pH5とする量・香料
適量・水
残実施例10に準じてミルクローションを調
製した。Example 13 Milk lotion (oil phase) wt%
Liquid paraffin 32, solid paraffin 4, cetanol
4. Sorbitan monostearate 1.5. Polyoxyethylene (2
0) Sorbitan monooleate 2.8 Propyl paraoxybenzoate 0.2 (aqueous phase) Kojic acid 2° Malic acid 0.5 ■--
Glutamic acid 1.0 Hyaluronic acid 0.01, Sodium hydroxide Amount to adjust pH to 5, Fragrance
Appropriate amount/water
A milk lotion was prepared according to the remaining Example 10.
実−5臼(例−1−仁YL−液一
(油相) wt%・
自己乳化型グリセリルモノステアレート 1.5・ポリ
オキシエチレンセチルエーテル 2゜・ステアリン
酸 2.0・セタノール
1.0・イソプロピルミリ
ステート 2゜・バラオキシ安息香酸ブ
チル 0.2(水相)
・コウジ酸 3.0・L
−グルタミン酸 20・L−ア
スパラギン酸 2.0・アラントイ
ン 0.1・水酸化ナトリ
ウム p H5,5とする量・水
残
実施例10に準じて乳液を調製した。Seed - 5 mortar (Example - 1 - Seed YL - Liquid 1 (oil phase) wt%
Self-emulsifying glyceryl monostearate 1.5, polyoxyethylene cetyl ether 2°, stearic acid 2.0, cetanol
1.0・Isopropyl myristate 2゜・Butyl hydroxybenzoate 0.2 (aqueous phase) ・Kojic acid 3.0・L
-Glutamic acid 20・L-aspartic acid 2.0・Allantoin 0.1・Sodium hydroxide Amount to make pH 5.5・Water
A milky lotion was prepared according to the remaining Example 10.
実施例15 化粧水
wt %
・ポリオキシエチレン(25)グリセリルモノピログル
タメートモノイソステアレート
1.0・エタノール
15.0・パラオキシ安息香酸メチル
0.1′コウジ酸
0゜7・エチレンジアミン四酢酸テトラナト
リウム 1.0・L
−グルタミン酸ジナトリウム 1.5・ヘチマ
水 2!、0・アラント
イン 0.トカルボキシメ
チルキチン 0.05・パラオキシ安息香酸
メチル 0.1・香料
適量・塩酸 pH
を5.8とする量・水 残
金成分を加熱溶解した後、pHを5.8とし冷却して化
粧水を調製した。Example 15 Lotion wt% ・Polyoxyethylene (25) glyceryl monopyroglutamate monoisostearate
1.0・Ethanol
15.0 Methyl paraoxybenzoate
0.1' kojic acid
0゜7・Tetrasodium ethylenediaminetetraacetate 1.0・L
-Disodium glutamate 1.5・Loofa water 2! ,0・Allantoin 0. Tocarboxymethyl chitin 0.05・Methyl paraoxybenzoate 0.1・Fragrance
Appropriate amount/hydrochloric acid pH
Amount of water to adjust the amount to 5.8 After heating and dissolving the remaining gold components, the pH was adjusted to 5.8 and cooled to prepare a lotion.
%i%16 パック
(A)
・カルボキシビニルポリマー 1.0・コ
ウジ酸 25D L−グ
ルタミン酸モノナトリウム 0.5・エチレンジア
ミン四酢酸シナl〜リウム 1.0キトサン乳酸塩
0.05・香料
適量・パラオキシ安息香酸メチル
0.1・水
残(B)
・炭酸カルシウム 0.3二酸
化チタン 0.02(C)
・エタノール 3.0上
記(A>成分を溶解、膨潤させた後、(B)成分を加え
、最後に(C)成分を加え混練し、パックを調製した。%i%16 Pack (A) ・Carboxyvinyl polymer 1.0・Kojic acid 25D Monosodium L-glutamate 0.5・Cynalium-ethylenediaminetetraacetic acid 1.0 Chitosan lactate
0.05・Fragrance
Appropriate amount/Methyl paraoxybenzoate
0.1・Water
Remainder (B) - Calcium carbonate 0.3 Titanium dioxide 0.02 (C) - Ethanol 3.0 After dissolving and swelling the above (A> component, add component (B), and finally add component (C). The mixture was added and kneaded to prepare a pack.
比較例3〜9
実施例10〜16の各化粧料と、これらの化粧料から有
機酸(塩)、酸性アミノ酸(塩)を除いた化粧料(ただ
し、pHは水酸化ナトリウムまたは塩酸により実施例の
pHと合わせた)をそれぞれ比較例3〜9とし、45°
Cに2ケ月間放置してpHの変化を調べた。その結果を
第4表に示す。Comparative Examples 3 to 9 Cosmetics from Examples 10 to 16 and cosmetics obtained by removing organic acids (salts) and acidic amino acids (salts) from these cosmetics (however, the pH was adjusted according to the examples using sodium hydroxide or hydrochloric acid) ) were used as Comparative Examples 3 to 9, respectively, and 45°
C for 2 months, and the change in pH was examined. The results are shown in Table 4.
(以下余白)
第4表
実施例17 クリーム
(油相) wt%・M
Cステアリン 10.0・流動パ
ラフィン 2.0・イソプロピ
ルミリステート 1.0・チルコール
20・水添ラノリン
1.0・グリセリンモノステアレー
ト1.5
・ポリオキシエチレン(20)セチル
エーテル 2.0・バ
ラオキシ安息香酸プロピル 0.2・香料
0.2(水相)
・コウジ酸 1.0・ク
エン酸 1.5・グリ
チルリチン酸モノアンモニウム 0.1・乳酸
1.0・水酸化ナトリ
ウム pH5,5とする量・水
残
実施例10に準じてクリームを調製した。(Margin below) Table 4 Example 17 Cream (oil phase) wt%・M
C Stearin 10.0・Liquid paraffin 2.0・Isopropyl myristate 1.0・Tyrchol
20. Hydrogenated lanolin
1.0・Glycerin monostearate 1.5・Polyoxyethylene (20) cetyl ether 2.0・Propyl roseoxybenzoate 0.2・Fragrance
0.2 (aqueous phase) Kojic acid 1.0 Citric acid 1.5 Monoammonium glycyrrhizinate 0.1 Lactic acid
1.0・Sodium hydroxide Amount to adjust pH to 5.5・Water
A cream was prepared according to the remaining Example 10.
害U1例−1,53璋−
く油相) wt%・流
動パラフィン 8.0ミツロウ
1.0・ステアリルア
ルコール 1.4・63−ステアリン
1.2・ポリオキシエチレン(
10)グリセリルトリステアレート
2.4ポリオキシエチレン(15)セチル
エーテル 0・8パラオ
キシ安息香酸ブチル 0.1(水相)
・コウジ酸 0.7エチ
レンジアミン4酢酸ジナトリウム 0.5グリシン
1.0・ヒアルロン酸
0.05・バラオキシ安息香
酸メチル 0.3・水酸化ナトリウム
pH5、8とする量実施例10に準じて乳液を
調製した。Harm U1 example - 1,53-gold oil phase) wt% liquid paraffin 8.0 beeswax 1.0 stearyl alcohol 1.4 63-stearin 1.2 polyoxyethylene (
10) Glyceryl tristearate
2.4 Polyoxyethylene (15) Cetyl ether 0.8 Butyl paraoxybenzoate 0.1 (aqueous phase) Kojic acid 0.7 Disodium ethylenediaminetetraacetate 0.5 Glycine
1.0・Hyaluronic acid
0.05・Methyl roseoxybenzoate 0.3・Sodium hydroxide
A milky lotion was prepared according to Example 10 in an amount to adjust the pH to 5 and 8.
火電舅19 パ・ンク
(A) wt%・コ
ウジ酸 20・酒石酸
1.0・L−グルタミ
ン酸モノナトリウム 0.3・L−リジン塩酸塩
1.0・グリチルレチン酸
0.02・L−プロリン
0.5・ブロデュウ100
2.0・ビーガム
5.0・スクワラン
20プロピレングリコール 5.
0、バラオキシ安息香酸メチル 0.3・
水酸化ナトリウム pH6,0にする量(B
)
・酸化亜鉛 10.0・カ
オリン 10.0(C)
・エタノール 5,0実
施例16に準じてパックを調製した。Fire power father-in-law 19 Park (A) wt% Kojic acid 20 Tartaric acid
1.0. Monosodium L-glutamate 0.3. L-lysine hydrochloride 1.0. Glycyrrhetinic acid
0.02・L-proline
0.5 Brodieu 100
2.0 Begum
5.0 Squalane
20 Propylene Glycol 5.
0, methyl roseoxybenzoate 0.3.
Sodium hydroxide Amount to adjust pH to 6.0 (B
) - Zinc oxide 10.0 - Kaolin 10.0 (C) - Ethanol 5.0 A pack was prepared according to Example 16.
比較例10〜12
実施例17.18.1つの各化粧料から、有機酸く塩)
、中性アミノ酸(塩)、酸性アミノ酸(塩)、塩基性ア
ミノ酸く塩)を除いた化粧料を調製し、それぞれ比較例
10.11.12としたくただし、pHは水酸化ナトリ
ウムにより対応する実施例と同じになるように調整した
)。Comparative Examples 10-12 Example 17.18. Organic acid salts from each cosmetic product)
, neutral amino acids (salts), acidic amino acids (salts), and basic amino acids (salts) were prepared as Comparative Examples 10, 11, and 12, respectively, but the pH was adjusted to the corresponding level using sodium hydroxide. (adjusted to be the same as the example).
実施例17〜19、比較例1O〜12の各化粧料を45
℃に2ケ月放置し、pHおよび色の変化を測定した。測
定条件は実施例2,5、比較例1.2(第2表)および
実施例10〜16、比較例3〜9(第71表)に従った
。測定結果を第5表に示す。Each cosmetic of Examples 17 to 19 and Comparative Examples 1O to 12 was
After being left at ℃ for 2 months, changes in pH and color were measured. The measurement conditions were as in Examples 2 and 5, Comparative Examples 1.2 (Table 2), Examples 10 to 16, and Comparative Examples 3 to 9 (Table 71). The measurement results are shown in Table 5.
以上の結果より、特定の有機酸(塩)、アミノ酸(塩)
の組合せにより、pHおよび色の変化を抑えたコウジ酸
配合の化粧料が得られることが分かる。From the above results, specific organic acids (salts) and amino acids (salts)
It can be seen that by the combination of the following, a cosmetic containing kojic acid with suppressed changes in pH and color can be obtained.
Uノと効−劃
本発明により、安定なコウジ酸含、有化粧料が得られる
。According to the present invention, a stable cosmetic composition containing kojic acid can be obtained.
Claims (1)
酸およびこれらの塩から選ばれる少なくとも1種とコウ
ジ酸を含有することを特徴とする化粧料。 2、有機ジカルボン酸、有機テトラカルボン酸、高分子
ポリカルボン酸、酸性アミノ酸およびこれらの塩から選
ばれる少なくとも1種とコウジ酸を含有することを特徴
とする化粧料。 3、下記成分(A)、(B)、(C)を必須成分として
含有することを特徴とする化粧料。 (A)有機モノカルボン酸、中性アミノ酸、塩基性アミ
ノ酸およびこれらの塩から選ばれる少なくとも1種 (B)有機ジカルボン酸、有機トリカルボン酸、有機テ
トラカルボン酸、高分子ポリカルボン酸、酸性アミノ酸
およびこれらの塩から選ばれる少なくとも1種 (C)コウジ酸[Scope of Claims] 1. A cosmetic containing at least one selected from organic monocarboxylic acids, neutral amino acids, basic amino acids, and salts thereof and kojic acid. 2. A cosmetic containing at least one selected from organic dicarboxylic acids, organic tetracarboxylic acids, high-molecular polycarboxylic acids, acidic amino acids, and salts thereof, and kojic acid. 3. A cosmetic containing the following components (A), (B), and (C) as essential components. (A) At least one selected from organic monocarboxylic acids, neutral amino acids, basic amino acids, and salts thereof (B) organic dicarboxylic acids, organic tricarboxylic acids, organic tetracarboxylic acids, high molecular polycarboxylic acids, acidic amino acids, and At least one selected from these salts (C) kojic acid
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63159600A JP2751965B2 (en) | 1988-04-30 | 1988-06-27 | Cosmetics |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63-107959 | 1988-04-30 | ||
JP10795988 | 1988-04-30 | ||
JP63159600A JP2751965B2 (en) | 1988-04-30 | 1988-06-27 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0228105A true JPH0228105A (en) | 1990-01-30 |
JP2751965B2 JP2751965B2 (en) | 1998-05-18 |
Family
ID=26447930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63159600A Expired - Lifetime JP2751965B2 (en) | 1988-04-30 | 1988-06-27 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2751965B2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0381057A2 (en) * | 1989-01-28 | 1990-08-08 | Sansho Seiyaku Co., Ltd. | Chemical composition for external application |
JPH0311010A (en) * | 1989-06-08 | 1991-01-18 | Sansho Seiyaku Co Ltd | External application for suppressing generation of melanin |
JPH07101822A (en) * | 1993-09-30 | 1995-04-18 | Sansho Seiyaku Co Ltd | Skin agent for external use |
US5486624A (en) * | 1994-02-01 | 1996-01-23 | Pacific Corporation | Kojic acid derivative |
US5523421A (en) * | 1993-11-16 | 1996-06-04 | Pacific Corporation | Kojic acid derivatives |
FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
JPH0912442A (en) * | 1995-06-26 | 1997-01-14 | L'oreal Sa | Use of combination of alpha-hydroxy acid and titanium oxide for lightening skin color |
JPH1171223A (en) * | 1997-08-29 | 1999-03-16 | Shiseido Co Ltd | Skin preparation for external use for preventing obscurity |
FR2791564A1 (en) * | 1999-04-02 | 2000-10-06 | Jean Morelle | Skin protecting composition contains azelaic acid neutralized by basic amino acid such as lysine or arginine |
JP2002080321A (en) * | 2000-06-20 | 2002-03-19 | Kyowa Hakko Kogyo Co Ltd | Cosmetic |
US6710076B2 (en) | 1994-10-24 | 2004-03-23 | Physician's Choice Of Arizona, Inc. | Hydroxy-kojic acid skin peel |
JP2004315384A (en) * | 2003-04-14 | 2004-11-11 | Kyowa Hakko Kogyo Co Ltd | Bleaching agent |
JP2013520409A (en) * | 2010-02-22 | 2013-06-06 | ロレアル | Cosmetic composition |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61109705A (en) * | 1984-11-01 | 1986-05-28 | Sansho Seiyaku Kk | Whitening cosmetics |
JPS62108804A (en) * | 1985-11-06 | 1987-05-20 | Pola Chem Ind Inc | Cosmetic |
JPS62178506A (en) * | 1986-02-01 | 1987-08-05 | Sansho Seiyaku Kk | Melanin formation suppressing external preparation |
JPH01100114A (en) * | 1987-10-12 | 1989-04-18 | Sansho Seiyaku Co Ltd | External preparation for skin |
JPH01100112A (en) * | 1987-10-12 | 1989-04-18 | Sansho Seiyaku Co Ltd | External preparation for skin |
-
1988
- 1988-06-27 JP JP63159600A patent/JP2751965B2/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61109705A (en) * | 1984-11-01 | 1986-05-28 | Sansho Seiyaku Kk | Whitening cosmetics |
JPS62108804A (en) * | 1985-11-06 | 1987-05-20 | Pola Chem Ind Inc | Cosmetic |
JPS62178506A (en) * | 1986-02-01 | 1987-08-05 | Sansho Seiyaku Kk | Melanin formation suppressing external preparation |
JPH01100114A (en) * | 1987-10-12 | 1989-04-18 | Sansho Seiyaku Co Ltd | External preparation for skin |
JPH01100112A (en) * | 1987-10-12 | 1989-04-18 | Sansho Seiyaku Co Ltd | External preparation for skin |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0381057A3 (en) * | 1989-01-28 | 1991-05-08 | Sansho Seiyaku Co., Ltd. | Chemical composition for external application |
EP0381057A2 (en) * | 1989-01-28 | 1990-08-08 | Sansho Seiyaku Co., Ltd. | Chemical composition for external application |
JPH0311010A (en) * | 1989-06-08 | 1991-01-18 | Sansho Seiyaku Co Ltd | External application for suppressing generation of melanin |
US5599528A (en) * | 1993-09-30 | 1997-02-04 | Sansho Seiyaku Co., Ltd. | Preparation for epidermis |
JPH07101822A (en) * | 1993-09-30 | 1995-04-18 | Sansho Seiyaku Co Ltd | Skin agent for external use |
US5523421A (en) * | 1993-11-16 | 1996-06-04 | Pacific Corporation | Kojic acid derivatives |
US5486624A (en) * | 1994-02-01 | 1996-01-23 | Pacific Corporation | Kojic acid derivative |
US6710076B2 (en) | 1994-10-24 | 2004-03-23 | Physician's Choice Of Arizona, Inc. | Hydroxy-kojic acid skin peel |
JPH0912442A (en) * | 1995-06-26 | 1997-01-14 | L'oreal Sa | Use of combination of alpha-hydroxy acid and titanium oxide for lightening skin color |
WO1997002807A1 (en) * | 1995-07-07 | 1997-01-30 | C 3 D | Depigmenting cosmetic skin-care composition and use thereof |
US6190664B1 (en) * | 1995-07-07 | 2001-02-20 | C 3 D | Depigmenting cosmetic skin-care composition and use thereof |
FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
JPH1171223A (en) * | 1997-08-29 | 1999-03-16 | Shiseido Co Ltd | Skin preparation for external use for preventing obscurity |
FR2791564A1 (en) * | 1999-04-02 | 2000-10-06 | Jean Morelle | Skin protecting composition contains azelaic acid neutralized by basic amino acid such as lysine or arginine |
JP2002080321A (en) * | 2000-06-20 | 2002-03-19 | Kyowa Hakko Kogyo Co Ltd | Cosmetic |
JP2004315384A (en) * | 2003-04-14 | 2004-11-11 | Kyowa Hakko Kogyo Co Ltd | Bleaching agent |
JP2013520409A (en) * | 2010-02-22 | 2013-06-06 | ロレアル | Cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
JP2751965B2 (en) | 1998-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0228105A (en) | Cosmetic | |
KR20070087488A (en) | Hair restorer | |
KR20080111601A (en) | Composition containing vitamin c | |
JP4681132B2 (en) | Nitric oxide synthase production promoter and cosmetic or pharmaceutical composition | |
JPH05170637A (en) | Beautifying and whitening cosmetic | |
JPH05271046A (en) | Dermal medicine for external use | |
JPH05170636A (en) | Beautifying and whitening cosmetic | |
KR20100014431A (en) | Composition for external application to skin | |
JPH11199426A (en) | Cosmetic | |
JP3923849B2 (en) | Method for inhibiting discoloration of tannin-containing composition and composition thereof | |
JP2906269B2 (en) | External preparation for skin | |
JPH01100112A (en) | External preparation for skin | |
JP2003267830A (en) | Liquid cosmetic | |
JPH10182404A (en) | Preparation for external use for skin | |
JP2004018483A (en) | Agent for promoting uptake of basic amino acid in cell and cosmetic or pharmaceutical composition | |
JP2002226494A (en) | Method for preventing crystallization of l-ascorbyl magnesium phosphate and skin care preparation using the method | |
US5985922A (en) | Amino acid derivatives and active oxygen-resisting agent | |
JPH0782127A (en) | Cosmetic | |
JPH05301814A (en) | Cosmetic | |
JPH02237906A (en) | External preparation for skin | |
EP0344708A2 (en) | Composition for external application to skin | |
JPS61130204A (en) | Skin cosmetic | |
WO2018220916A1 (en) | Topical composition | |
JPH0533922B2 (en) | ||
TW200808717A (en) | Skin whitening agent containing zinc as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 11 |